PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Cell. Author manuscript; available in PMC Sep 7, 2011.
Published in final edited form as:
PMCID: PMC3168554
NIHMSID: NIHMS214683
Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components
Chan-Yen Ou,1,5 Vivian Y. Poon,2,5 Celine I. Maeder,1 Shigeki Watanabe,3 Emily K. Lehrman,1 Amy K. Y. Fu,4 Mikyoung Park,1 Wing-Yu Fu,4 Erik M. Jorgensen,3 Nancy Y. Ip,4 and Kang Shen1*
1Department of Biology, Howard Hughes Medical Institute, Stanford University, 385 Serra Mall, California 94305, USA
2Neurosciences Program, Stanford University School of Medicine, 385 Serra Mall, Stanford, California 94305, USA
3Department of Biology, Howard Hughes Medical Institute, University of Utah, Salt Lake City, UT 84112-0840, USA
4Department of Biochemistry, Biotechnology Research Institute and Molecular Neuroscience Center, Hong Kong University of Science & Technology, Clear Water Bay, Kowloon, Hong Kong, China
* Corresponding author Contact: kangshen/at/stanford.edu; 1-650-724-4255
5These authors contributed equally to this work
Polarized trafficking of synaptic proteins to axons and dendrites is crucial to neuronal function. Through forward genetic analysis in C. elegans, we identified a cyclin (CYY-1) and a cyclin-dependent Pctaire kinase (PCT-1) necessary for targeting presynaptic components to the axon. Another cyclin-dependent kinase, CDK-5, and its activator p35, act in parallel to and partially redundantly with the CYY-1/PCT-1 pathway. Synaptic vesicles and active zone proteins mostly mislocalize to dendrites in animals defective for both PCT-1 and CDK-5 pathways. Unlike the kinesin-3 motor, unc-104/Kif1a mutant, cyy-1 cdk-5 double mutants have no reduction in anterogradely moving synaptic vesicle precursors (SVPs) as observed by dynamic imaging. Instead, the number of retrogradely moving SVPs is dramatically increased. Furthermore, this mislocalization defect is suppressed by disrupting the retrograde motor, the cytoplasmic dynein complex. Thus, PCT-1 and CDK-5 pathways direct polarized trafficking of presynaptic components by inhibiting dynein-mediated retrograde transport and setting the balance between anterograde and retrograde motors.
Neurons are highly specialized cells capable of transmitting and processing information through their polarized cellular processes: dendrites receive signals through neurotransmitter receptors and transform these signals into electrical impulses, while axons convert these electrical impulses into chemical signals at presynaptic sites through synaptic vesicle cycles. Therefore, the localization of synaptic vesicles and other active zone components at axonal presynaptic sites is absolutely essential for neuronal function.
How are these axonal or dendritic molecules localized appropriately? There are multiple possible routes that diverge at the levels of sorting, trafficking, and retention (Horton and Ehlers, 2003). Proteins are sorted into different carrier vesicles in the cell body. Certain vesicles are specifically transported to one compartment, while others travel into multiple compartments before being selectively retained in one compartment.
The sheer length of most axons and their lack of protein synthesis machinery demands efficient transport systems to traffic synaptic vesicle precursors (SVPs) and active zone components from the cell body to the axons. Intriguingly, studies in dissociated neuronal cultures showed that several axonal proteins such as synaptic vesicle v-SNARE VAMP2/synaptobrevin, cell adhesion molecule L1/neuron-glia cell adhesion molecule NgCAM, and sodium channel Nav1.2, are initially transported to both the axon and dendrites but later localize to the axon through transcytosis (Burack et al., 2000; Garrido et al., 2001; Sampo et al., 2003; Wisco et al., 2003; Yap et al., 2008). These results indicate that there are trafficking mechanisms both to bring axonal cargo to the dendrite and to transport them into axons.
The microtubule cytoskeleton and related molecular motors are largely responsible for the long-range trafficking of axonal components. Microtubules are oriented plus-end distal in the axon, while they have mixed polarity in dendrites (Baas et al., 1988). The vast majority of the members of the kinesin superfamily move unidirectionally toward the plus end of microtubules, while cytoplasmic dyneins transport cargo in the opposite direction (Hirokawa and Takemura, 2005; Vale, 2003). These molecular motors are highly regulated. They recognize various cargo through direct binding or by utilizing different adaptors. Different adaptors are sufficient to guide motors toward axons or dendrites. Overexpression of the KIF-5-interacting domain of glutamate receptor-interacting protein 1 (GRIP) causes KIF-5 to accumulate in dendrites while overexpression of JIP3/Sunday driver leads to KIF-5 accumulation in axons (Setou et al., 2000). Other regulators can associate with motors and modulate their activity. For example, the retrograde motor dynein and its regulator LIS1 associate with Nudel, a factor phosphorylated by cyclin-dependent kinase-5 (CDK-5) (Niethammer et al., 2000; Sasaki et al., 2000). Inhibiting CDK-5 phosphorylation of NUDEL in vitro disrupts neurite morphology, a defect observed in dynein mutants as well. The tight regulation of motors is not surprising given the wide array of cargo that they transport to diverse locations.
In vivo studies identified two kinesin family motors and the dynein complex to be important for trafficking presynaptic components. UNC-104/Imac/KIF1A, a member of the kinesin-3 family, is the primary motor responsible for transporting SVPs. Mutant worms and flies lacking this gene product show almost complete failure of axonal trafficking — most SVPs accumulate in neuronal cell bodies (Hall and Hedgecock, 1991; Pack-Chung et al., 2007). The conventional kinesin-1/KIF5/KHC also plays a role in this process as it binds SVPs, and disruption of this motor or its adaptor reduces the levels of SVPs and the active zone protein bassoon at presynaptic sites (Cai et al., 2007; Sato-Yoshitake et al., 1992). Thirdly, disrupting components of the cytoplasmic dynein complex leads to misaccumulation of synaptic proteins (Fejtova et al., 2009; Koushika et al., 2004). Taken together, these results indicate that the localization of presynaptic components requires the cooperation of multiple motors. However, how motors are regulated to distinguish between axons and dendrites, how presynaptic cargo is deposited specifically at presynaptic sites, and how different motors interact with one another are important questions that remain to be addressed.
Here, we utilized an in vivo system in C. elegans to study the intracellular trafficking of SVPs and active zone proteins. We identified two cyclin-dependent kinase pathways that are essential for axonal localization of presynaptic components. Our results suggest that these kinase pathways regulate the localization of presynaptic components by inhibiting retrograde trafficking that is likely mediated through the dynein motor.
Presynaptic components mislocalize to the dendrite of the DA9 motor neuron in wy575 and wy302 mutants
The cholinergic motor neuron DA9 elaborates a morphologically and molecularly distinct axon and dendrite, and is well suited for the study of mechanisms regulating the polarized localization of axonal and dendritic proteins in vivo. We visualized both presynaptic components and dendritic proteins in DA9 using cell-specific promoters (itr-1 pB or mig-13) to express fluorescently tagged protein markers in vivo. Consistent with electron microscopic reconstruction data (White et al., 1976), synaptic vesicle proteins and active zone markers localize only to a discrete segment of the axon while several proteins localize selectively to the dendrite (Klassen and Shen, 2007; Poon et al., 2008).
To identify factors important for localizing presynaptic components, we visually screened randomly mutagenized animals for mutants with abnormal distribution patterns of presynaptic components. We isolated two mutants with similar and fully penetrant defects with presynaptic markers present in both axons and dendrites. In both wy575 and wy302 mutants, synaptic vesicle-associated RAB-3, active zone component SYD-2/liprin-α, synaptic vesicle transmembrane proteins SNB-1/synaptobrevin and SNG-1/synaptogyrin mislocalize to the DA9 dendrite (Figure 1B, C, H, I compared with Figure 1A, G, Figure S1A-L). DA9 axonal and dendritic morphology is otherwise normal. Furthermore, the majority of the presynaptic proteins is still distributed in the axon, and these proteins colocalize with one another in the normal synaptic domain (Figure 1H, I). These results indicate that except for mislocalized presynaptic components, many aspects of DA9 development, including axon guidance, dendrite outgrowth, and synaptic target selection, are normal in these two mutants. Consistent with this notion, while both wy575 and wy302 mutants have slightly lower brood sizes, they are fertile, active, and exhibit largely normal locomotion.
Figure 1
Figure 1
Synaptic Vesicle-Associated RAB-3 and Active Zone Protein SYD-2/Liprin-α Mislocalize to the DA9 Dendrite in wy575 or wy302 Mutants,.
wy575 and wy302 are mutant alleles of a cyclin-dependent kinase and a cyclin, respectively
Using single nucleotide polymorphism mapping, transgenic rescue, and sequence analysis, we mapped the wy575 mutation to pct-1, which encodes a highly conserved Pctaire kinase of the cyclin-dependent kinase family (Figure S1U, V). Pctaire kinases have been implicated in neurite outgrowth, exocytosis, and tau phosphorylation (Graeser et al., 2002; Herskovits and Davies, 2006; Liu et al., 2006). cDNA sequences predict three isoforms of PCT-1 with common C-terminal kinase domains and variable N-terminal sequences. wy575 is a missense mutation of a highly conserved aspartic acid residue in the ATP-binding pocket of the kinase (D377N). We also examined the phenotypes of two different deletion alleles of pct-1 in DA9: one affects two of the three isoforms (ok1707) while the other removes the kinase domain in all three isoforms and is a predicted null (tm2175). ok1707 mutants have no mislocalization defect, while tm2175 mutants are indistinguishable from wy575 mutants (Figure 2J), suggesting that the third isoform is sufficient and that both wy575 and tm2175 are likely null alleles.
Figure 2
Figure 2
PCT-1, CYY-1, CDK-5, and CDKA-1/p35 Act in Two Pathways in DA9.
Using similar methods, we mapped wy302 at the genetic locus ZK353.1. This gene encodes two highly similar isoforms containing a predicted cyclin domain. It is orthologous to mammalian cyclin Y that has not been studied previously (Figure S1X, Y). We named the gene CYY-1 (Cyclin Y). The wy302 allele results in a stop codon in the ninth amino acid and likely represents a null allele.
PCT-1, CYY-1, CDK-5, and CDKA-1/p35 act cell-autonomously in DA9 to ensure the polarized localization of presynaptic components
Since the phylogenetic analysis shows that PCT-1 is most closely related to CDK-5 (Figure S1U), we further exam CDK-5 and other CDK mutants. While mutations in CDK-1, CDK-7, and CDK-8 have no effect (data not shown), null mutations in cdk-5 or its activator cdka-1/p35 lead to dendritic accumulation of presynaptic components (Figure 2A, B, Figure S1). Like the pct-1 and cyy-1 mutants, this mislocalization defect in cdk-5 or cdka-1/p35 mutants is fully penetrant. The mutant animals have normal DA9 guidance and morphology, and do not exhibit obvious defects in locomotory behavior.
We subsequently determined if these four genes are expressed endogenously in DA9. Cytoplasmic fluorophore under the control of their endogenous promoters, revealed fluorescence in DA9 as well as other ventral cord motor neurons (data not shown). CYY-1 is also expressed in other tissues such as the gut and gonad. Using the itr-1 pB promoter that drives expression specifically in DA9 in the tail, we asked if DA9-specific expression of each gene is sufficient to rescue the mislocalization defect of SVPs. For each gene, we generated two independent transgenic strains expressing the corresponding cDNA or genomic fragment in DA9. Expression of these four genes in DA9 almost completely rescues the mutant phenotype, suggesting that PCT-1, CYY-1, CDK-5, and CDKA-1/p35 act cell-autonomously in DA9 (Figure 2C).
PCT-1, CYY-1, CDK-5, and CDKA-1/p35 act in parallel pathways
Since pct-1, cyy-1, cdk-5, and cdka-1/p35 mutants have similar defects, we investigated their genetic relationships. Using putative null mutants, we generated all six combinations of double mutants and compared them with the single mutants (Figure 2D-I). Quantitative analysis of GFP::RAB-3 distribution in the DA9 axon and dendrite showed that between 19-47% of total RAB-3 fluorescence is present in the dendrite of these single mutants compared to 0.3% in wild-type animals (Figure 2J). As cyy-1; pct-1 double mutant animals are indistinguishable from each single mutants, PCT-1 and CYY-1 likely function in the same genetic pathway. Likewise, cdka-1/p35 cdk-5 double mutant animals have a mislocalization defect similar to cdk-5 single mutants, a result one would expect if CDKA-1/p35 activates CDK-5.
The other four double mutants, on the other hand, exhibit dramatically enhanced mislocalization defects. Nearly all SVPs (86-98%) are present in the DA9 dendrite in the cdk-5; pct-1, cdka-1/p35; pct-1, cyy-1 cdk-5, and cdka-1/p35 cyy-1 double mutants (Figure 2F-J). The active zone protein SYD-2/liprin-α is similarly dramatically mislocalized in these double mutants, suggesting that trafficking and localization of multiple presynaptic components are defective (Figure S2). To address if these defects are specific to the cholinergic DA9 neuron, we examined the localization of synaptic vesicle-associated RAB-3 in other neurons. We found that the GABAergic DD motor neurons and the RIA interneurons are also severely affected in cyy-1 cdk-5 double mutants and GFP::RAB-3 mislocalizes to dendrites or dendritic segments (Figure S3). Intriguingly, the localization of synaptic vesicle markers in the cholinergic DB motor neurons is only mildly affected in cyy-1 cdk-5 double mutants (data not shown), suggesting that these two pathways are required for many but not all neurons. Not surprisingly, these four double mutants are largely paralyzed, indicating a loss of functional synapses in motor neurons. These results are consistent with pct-1 and cyy-1 acting in a pathway parallel to cdk-5 and cdka-1/p35 in multiple neurons. The observed drastic enhancement further highlights that these two pathways are essential for the polarized localization of presynaptic components.
To definitively understand the synaptic structural defects in the cyy-1 cdk-5 double mutants, we reconstructed segments (4-7μm) of the dorsal nerve cord using serial electron microscopy (EM) from three cyy-1 cdk-5 double mutant animals and three wild-type control animals. Consistent with our findings with fluorophore-tagged synaptic markers, we found that the number of synaptic vesicles and active zones in the DA and DD axons are significantly reduced whereas presynaptic specializations in the DB neurons appear normal (Figure 3 and unpublished data, Watanabe and Shen). Since the reconstruction was performed where the DA1 to DA4 neurons form synapses, the synaptic vesicle localization defect in DA neurons is not limited to DA9, but is true for the anterior DA neurons as well. This EM analysis also revealed that the size and appearance of the synaptic vesicles in cyy cdk-5 mutants is indistinguishable from that in wild-type controls. Furthermore, the appearance of the muscle arms and their contacts with the motor neurons are largely normal, arguing that the wiring of the motor circuits remains intact in the mutant animals (data not shown).
Figure 3
Figure 3
The Number of Synaptic Vesicles and Active Zones is Reduced in the Dorsal Axons of DA Neurons in cyy-1 cdk-5 Double Mutants.
The close phylogenetic relationship, the similarity of their loss-of-function phenotypes, and the enhanced phenotype of the double mutants indicate that the PCT-1 and CDK-5 pathways might perform similar and redundant functions in DA9. To directly address this, we examined if over-activating one pathway could compensate for the loss of the other pathway. Indeed, we found that overexpression of PCT-1 in cdk-5 mutants significantly rescues their mislocalization defects, and likewise, overexpression of CDK-5 significantly rescues defects of pct-1 mutant animals (Figure 4A).
Figure 4
Figure 4
CYY-1 Activates PCT-1 and Possibly CDK-5.
CYY-1 acts as an essential activator of PCT-1
While it is well established that p35 directly binds to and activates CDK-5 (Lew et al., 1994; Tsai et al., 1994; Uchida et al., 1994), the interaction between CYY-1 and PCT-1 has not been studied. No vertebrate cyclin is known to activate Pctaire kinases (Liu et al., 2006). We therefore tested if CYY-1 associates with and activates PCT-1 using tagged recombinant CYY-1 and PCT-1 in 293T cells. We observed that CYY-1 and PCT-1 robustly coimmunoprecipitate with each other regardless of the tag we used to perform the pull-down experiment (Figure 4B). Furthermore, the kinase activity of PCT-1 is strictly dependent on the presence of CYY-1 (Figure 4C). Consistently, overexpression of functional PCT-1 completely fails to rescue the cyy-1 mutants, indicating that the function of PCT-1 depends on CYY-1 (Figure 4D). These results strongly suggest that CYY-1 directly binds and activates PCT-1 to regulate the localization of presynaptic components.
If PCT-1 is the only downstream factor of CYY-1, CYY-1 should have no activity in pct-1 null mutant animals. However, we observed that overexpression of CYY-1 significantly rescues the mislocalization defect in pct-1(tm2175) mutant animals (Figure 4D). This indicates that overexpression of CYY-1 can affect the localization of presynaptic components through a mechanism independent of PCT-1. A primary candidate is CDK-5 since it is closely related to PCT-1 and we observed that the CDK-5 transgene that robustly rescues pct-1 mutant animals only marginally rescues cyy-1 mutant animals (Figure 4A). As presented in Figure 4D, the CYY-1 transgene that rescues the mislocalization defect in pct-1 mutants completely fails to rescue the mislocalization defect in cdk-5; pct-1 or cdka-1/p35; pct-1 double mutants. Taken together, these genetic interaction studies indicate that CYY-1 acts upstream of PCT-1 and can also potentially activate the CDKA-1/p35-CDK-5 pathway.
To further test whether CYY-1 can directly activate CDK-5, we performed in vitro kinase assays. We found that the kinase activity of CDK-5 can indeed be stimulated by CYY-1 suggesting that CYY-1 might also be an activator of CDK-5 (Figure S4A).
Subcellular localization of PCT-1, CYY-1, CDK-5, and CDKA-1/p35
Next, we examined the subcellular localization of PCT-1, CYY-1, CDK-5, and CDKA-1/p35. We found that CDK-5::YFP predominantly localizes to presynaptic sites and is present as faint puncta in the dendrite (Figure S4C). CDKA-1/p35::YFP shows a presynaptic distribution in the axon and a punctate localization pattern in the dendrite (Figure S4E). The localization of CDK-5 is completely dependent on UNC-104/KIF1A (data not shown). Consistent with the presynaptic localization of the vertebrate CDK-5 (Tomizawa et al., 2002), these two distribution patterns suggest that CDK-5 and CDKA-1/p35 are likely to be associated with presynaptic components.
Interestingly, CDK-5 and PCT-1 have very different localization patterns. PCT-1::GFP is diffusely localized within DA9 and labels both the dendrite and axon evenly (Figure S4B). CYY-1::YFP is also present in both axons and dendrites, but is enriched in the dendrite and proximal axon (Figure S4D). Taken together, if CYY-1 is required for the activity of PCT-1, one would imagine that the activity of PCT-1 is highest in the dendrite and lowest in the synaptic domain and distal axon.
Collectively, these data suggest that although both PCT-1 and CDK-5 affect similar biological processes, their exact cell biological functions in vivo might be different. However, they can substitute for each other when overexpressed in the single mutant background.
Dendritic mislocalization of presynaptic components in CDK mutants is unlikely to be caused by axon-dendrite specification or synapse assembly defects
After establishing the genetic and biochemical interactions between PCT-1, CYY-1, CDK-5, and CDKA-1/p35, we considered the following three possibilities that may lead to dendritic presynaptic components: 1, a defect in axon-dendrite specification; 2, a failure of local assembly at presynaptic specializations; 3, an impairment of intracellular transport of presynaptic components.
To address the first possibility, we examined DA9 axonal and dendritic guidance and outgrowth, trafficking of plus- and minus-end directed motors, dendritic proteins, and a non-synaptic axonal cargo. Both the timing and directionality of axonal and dendritic outgrowth are normal in cyy-1 cdk-5 double mutants (Figure S5A-D, data not shown). The overall MT organization in both the axon and dendrite is generally unaltered in the absence of the CDK pathways assayed by the subcellular distribution of MT-based motors (Figure S5E-H). Futhermore, we examined four dendritic proteins including CAM-1/ROR receptor tyrosine kinase, UNC-9/innexin, DYS-1/dystrophin, and fibrillin (Poon et al., 2008; Sieburth et al., 2005) and they localize nomally to dendrites in cyy-1 cdk-5 mutant animals (Figure S5I-P). Glutamate receptor localizes to dendrite of another neuron RIA, further indicating that trafficking of dendritic cargo is unaffected (Figure S3H, K). Lastly, we investigated if other axonal cargo are trafficked normally. TOM20, a subunit of the mitochondrial translocase complex, remains present in the axon in cyy-1 cdk-5 mutant animals (Figure S5Q-R), suggesting that non-presynaptic axonal cargo continues to be trafficked appropriately to the axon. Taken together, our data suggest that general axon and dendrite specification is normal in the absence of the CDK pathways and that the CDKs specifically affect localization of presynaptic components and not other axonal or dendritic cargo.
Is the failure of local assembly at presynaptic specializations the direct cause for dendritic mislocalization of presynaptic components in cdk-5 or pct-1 mutant? Since cdk-5 or pct-1 single mutants have a relatively normal accumulation of RAB-3 in the presynaptic region compared with the syd-1; syd-2/liprin-α double mutants that have severe presynaptic assembly defects in DA9 whereas cdk-5 or pct-1 single mutants exhibit much more severe accumulation of RAB-3 in the dendrites, there is no correlation between defective presynaptic assembly and the accumulation of stable RAB-3 puncta in the dendrite (Figure S5S-T). It is thus unlikely that the assembly defect alone can fully account for the dramatic mislocalization of presynaptic components in cyy-1 cdk-5 double mutants.
We then considered the third possibility that the CDK pathways regulate intracellular transport of presynaptic components. Since intracellular transport occurs continuously throughout the life of the neuron, we expect the CDKs to be required continuously if they regulate transport. Using a temperature-dependent silencing strategy (Poon et al., 2008), we observed that disruption of PCT-1 or CDK-5 late in development is sufficient to mislocalize SVPs to the dendrite. In addition, rescuing PCT-1 or CDK-5 late in development is sufficient to partially remove ectopic SVPs from the dendrite (Figure S6A-C). These findings suggest that both CDKs are required to maintain the polarized localization of SVPs and that this defect is reversible.
PCT-1 and CDK-5 genetically interact with the kinesin motor UNC-104/KIF1A
To further understand how the CDK pathways regulate molecular transport, we examined the primary motor responsible for SVP transport, UNC-104/KIF1A, in greater depth. Consistent with previous reports (Hall and Hedgecock, 1991), we found that RAB-3 is completely absent from the axon of unc-104 mutants, suggesting that UNC-104 is the key anterograde motor responsible for the axonal transport of SVPs. Surprisingly, we also found that SVPs dramatically accumulate in the DA9 cell body and dendrite of unc-104 mutants, a phenotype similar to that observed in cyy-1 cdk-5 double mutants (Figure 5B). This distribution pattern indicates that there might be another motor that transports SVPs into the dendrite in the absence of the UNC-104 motor. The similar phenotypes caused by disrupting both CDK pathways or by mutations in UNC-104 suggest that they might be involved in the same biological process. Consistent with this notion, the unc-104; cyy-1 cdk-5 triple mutants are indistinguishable from the unc-104 single mutant (Figure 5F).
Figure 5
Figure 5
The CDKs Affect Axonal Transport of Presynaptic Components.
To further understand the relationship between UNC-104 and the CDK pathways, we overexpressed UNC-104 in the absence of both CDK pathways. As seen in Figures 5D and E, UNC-104 expression leads to a partial suppression of the dendritic RAB-3 phenotype. In about 30% of the animals, the dendritic RAB-3 signal is completely absent, suggesting that overproduction of UNC-104 can partially compensate for the loss of both CDK pathways by trafficking SVPs to the axon (Figure 5E). However, despite the absence of dendritic RAB-3 in these animals, their dorsal axonal RAB-3 distribution is still significantly different from that in wild-type animals (Figure 5D). There are fewer and dimmer RAB-3 puncta, which are spread over a larger than normal segment of the dorsal axon. Though these results suggest that the CDKs are likely also involved in events distinct from UNC-104-mediated anterograde transport, they are consistent with the CDK pathways affecting intracellular transport of presynaptic components.
PCT-1 and CDK-5 inhibit retrograde transport of SVPs
To further elucidate how the CDK pathways affect intracellular transport, we performed time-lapse imaging experiments to visualize transporting SVPs in DA9 in vivo. We found that there are numerous small RAB-3 puncta in the axonal segment between the cell body and the dorsal synaptic domain (Figure 6A). These dim puncta are often motile during imaging sessions that last up to a minute, unlike synaptic RAB-3 puncta that remain stable over several days (data not shown). These motile RAB-3 puncta are missing from the axon in unc-104 mutants, suggesting that trafficking utilizes the same molecular motor as the synaptic vesicles. Hence, we hypothesize that these small puncta represent motile SVPs during axonal transport.
Figure 6
Figure 6
The CDKs inhibit retrograde transport of presynaptic components.
Time-lapse imaging experiments were performed on the dorsal asynaptic segment of the axon immediately proximal to the synaptic region of DA9 (Figure 6A-C). Measurements in wild-type animals revealed that 76% of the movements are toward the distal axon (anterograde), while 24% of the moving events are retrograde. The average speed of anterograde events is 1.9 μm/s, similar to the speed of dense core vesicles measured in vivo in C. elegans (Zahn et al., 2004). The average speed of the retrograde movements is 2.3 μm/s, similar to the speed of the retrograde motor dynein in living Dictyostelium cells (Ma and Chisholm, 2002). In order to understand if UNC-104 mediates anterograde movements, we measured the speed of anterograde events in a hypomorphic allele unc-104(e1265wy565). We found that only the speed of anterograde movements, but not retrograde events, is drastically reduced, suggesting that UNC-104 mediates anterograde movements (Figure 6D).
Besides the speed, we also measured the absolute number of anterograde and retrograde movement events. In unc-104(e1265wy565) mutants, the absolute number of anterograde events is drastically reduced, consistent with a weakened anterograde motor. Retrograde movement is also reduced, but to a lesser extent, probably due to the reduction of available SVPs to be measured in the mutant axon. Unlike unc-104(e1265wy565) mutants, the number of anterograde events is not significantly altered in cyy-1 cdk-5 double mutants. Instead, we observed a dramatic increase in retrograde events (194% compared with wild type, Figure 6E). Other dynamic parameters such as the run length and the pause rate remain unaffected in the cyy-1 cdk-5 double mutant (data not shown). Though unc-104(e1265wy565) mutants exhibit a severe impairment in anterograde SVP transport judging from the speed and number of anterograde events (Figure 6D and E), there is still significantly more RAB-3 signal in the unc-104(e1265wy565) mutant axon compared with the cyy-1 cdk-5 double mutant (Figure S6D-E). Based on these data, it is more likely that the dramatic increase in retrograde events in cyy-1 cdk-5 double mutants leads to an imbalance between anterograde and retrograde trafficking, ultimately resulting in failed assembly of presynaptic specializations in the axon and ectopic accumulation of presynaptic components in the dendrite. Similar dynamic measurements in cdk-5 or cyy-1 single mutants also reveal imbalanced trafficking with an abnormally high ratio of retrograde events. The amplitude of the defect in single mutants is smaller compared with that of the double mutants (Figure S6F). Hence, we hypothesize that the CDK pathways promote axonal transport by inhibiting retrograde transport. The most direct prediction of this hypothesis is that mutations in a retrograde motor should suppress the mislocalization defect in the CDK mutants.
PCT-1 and CDK-5 likely regulate SVP transport by inhibiting the cytoplasmic dynein complex
To further identify other downstream components of the CDK pathways, we conducted an unbiased cdk-5 suppressor screen and isolated five mutants with little or no dendritic RAB-3 in the cdk-5 mutant background. Four belong to a single complementation group and we mapped one of the four, wy622, which turned out to be a mutant allele of DHC-1, which encodes C. elegans ortholog of the heavy chain of the retrograde motor dynein (Figure 7A). Sequence analysis revealed that wy622 represents a point mutation in a conserved leucine residue in N-terminal region 2, while the previously characterized but unsequenced loss-of-function allele js319 represents a splice acceptor mutation at the end of intron 12 in the C-terminal conserved region (Figure 7A) (Koushika et al., 2004). We generated dhc-1; cdk-5 and dhc-1; pct-1 double mutants with the js319 allele. Similar to the wy622 allele, the js319 allele completely suppresses the dendritic accumulation of SVPs in either cdk-5 or pct-1 single mutants (Figure 7B, C). The dhc-1(js319) mutant also strongly suppresses the severe dendritic RAB-3 defect and reduces the number of retrogradely moving SVPs in cyy-1 cdk-5 double mutant animals (Figure 7E, J, ,6E).6E). These results suggest the CDK pathways promote axonal transport by inhibiting dynein-mediated retrograde movement in wild-type animals.
Figure 7
Figure 7
Loss-of-Function Mutations in Dynein Suppress the Mislocalization Defect in the CDK Mutants.
NUD-2 likely acts downstream of CDK-5 and PCT-1
To further establish the mechanistic link between the CDK-5 pathways and the cytoplasmic dynein complex, we considered NUD-2 as a direct target. NUD-2 is the worm ortholog of Nudel, a component of the cytoplasmic dynein complex that has been demonstrated as a substrate of CDK5 in vertebrate system (Niethammer et al., 2000; Sasaki et al., 2000). Indeed, we found that the null nud-2(ok949) allele completely suppresses the dendritic localization of SVPs in cdk-5 or pct-1 single mutants, and significantly suppresses the mislocalization phenotype in the cyy-1 cdk-5 double mutants (Figure 7F-J). This suppression by nud-2 is indistinguishable compared with the suppression by dhc-1. These results indicate that both DHC-1 and NUD-2 function downstream of the CDK-5/PCT-1 pathways and that CDK-5 and PCT-1 inhibit the activity of the cytoplasmic dynein complex (Figure 7K).
Our genetic and imaging experiments provide us with the following model: The axonal MTs are uniformly oriented with their plus-ends toward the axonal tip, while dendrites have mixed polarity with the preferred orientation being minus-ends toward the distal dendrite. Two antagonistic forces determine the localization of presynaptic components: the anterograde motor UNC-104/KIF1A transporting SVPs toward the axonal tip and the retrograde motor dynein trafficking SVPs toward the distal dendrite. PCT-1 and CDK-5 regulate the balance between the anterograde and retrograde trafficking, most likely by inhibiting dynein activity. In wild-type animals, PCT-1 and CDK-5 suppress dynein-mediated transport towards the dendrite, allowing the UNC-104 motor to dominate and achieve the axonal localization of presynaptic components. When both CDK pathways are defective, dynein activity is abnormally high, driving presynaptic components to dendrites.
CYY-1 activates PCT-1 and functions in localizing presynaptic components
Although a large body of evidence implicates cyclins in cell cycle regulation, there are some exceptions. For example, D-type cyclins are up-regulated in differentiating hematopoietic cells, quiescent myotubes, or in fibroblasts undergoing growth arrest, suggesting their non-mitogenic roles (Furukawa et al., 2000; Kiess et al., 1995; Meyyappan et al., 1998). Our findings suggest a post-mitotic role for CYY-1 in regulating intracellular transport and excluding presynaptic components from the DA9 dendrite. Like the D-type cyclins, CYY-1 may respond to extracellular cues by regulating signal transduction. Identifying the extrinsic signals important for the activity of CYY-1 would provide insight into the pathway that regulates the localization of presynaptic components.
Unlike CYY-1, the mammalian homologs of PCT-1 have been identified and characterized by several groups. Pctaire1, the best-characterized member of this kinase family, regulates neurite outgrowth in the Neuro2A neuroblastoma cell line (Graeser et al., 2002). Pctaire2 is associated with Trap (tudor repeat associator with Pctaire 2) and ik3-1/cables, the adaptor that functionally connects c-abl and CDK-5 to support neurite growth (Yamochi et al., 2001). The third member of this family, Pctaire3, is implicated in cytoskeletal regulation where it indirectly stimulates the phosphorylation of the MT associated protein, tau (Herskovits and Davies, 2006). However, the in vivo functions of these kinases and how they are regulated are poorly understood. Here we show genetically that cyy-1 falls in the same pathway with pct-1. We further show biochemically that CYY-1 binds to and activates PCT-1. It remains to be determined if mammalian cyclin Y activates Pctaire kinases.
Another upstream activator of Pctaire1 that has been characterized is CDK-5 (Liu et al., 2006). However, the C. elegans PCT-1 protein lacks the phosphorylation site for CDK-5 and is unlikely to be its substrate. With regards to downstream substrates, Pctaire1 has been shown to phosphorylate N-Ethylmaleimide-sensitive fusion protein, a factor important for membrane fusion (Cheng et al., 2002; Liu et al., 2006). Pctaire1 also interacts with p11/calpactin I light chain and 14-3-3, both of which are associated with multiple factors including c-kinase, Raf, Bcr, and PI3-kinase, but none of them have been identified as a substrate of Pctaire kinases (Le Bouffant et al., 1998). Due to the limited information available about the substrates of Pctaire kinases, it is hard to deduce a consensus substrate motif. However, similar to other CDKs or CDK-5, they likely phosphorylate the sequence (S/T)PX(K/H/R) (Liu et al., 2006). Further understanding of other features common to substrates of Pctaire kinases is needed to elucidate the mechanism of its function.
CDKs and axonal transport
In contrast to Pctaire kinases and cyclin Y, the proline-directed serine threonine kinase CDK-5 has been studied extensively and has been implicated in many aspects of neuronal development, such as neuronal migration, neurite outgrowth, synaptic formation, and neuronal survival (Gilmore et al., 1998; Kwon and Tsai, 1998; Ohshima et al., 1996; Yip et al., 2007). Astonishingly large numbers of putative CDK-5 substrates have been identified and these substrates are associated with cytoskeletal structures including MTs, as well as membrane dynamics and synaptic assembly (Cheung et al., 2006; Samuels et al., 2007; Smith, 2003; Xie et al., 2006). Among these, what might mediate the effect of CDK-5 or its related kinase PCT-1 on axonal trafficking?
Proper localization of presynaptic components involves multiple steps, including MT-based transport over long distances and local assembly at presynaptic specializations. As CDK-5 phosphorylates multiple MT-associated proteins and Pctaire3 indirectly phosphorylates tau (Herskovits and Davies, 2006), the CDKs may regulate the localization of presynaptic components by reorganizing the cytoskeleton. We did not detect major alterations to MT polarity and general axon morphology when both CDK pathways are disrupted, suggesting that cytoskeletal rearrangement is unlikely to be the major or only cause of mislocalized presynaptic components. However, our assay for MT polarity might not be sensitive enough to detect subtle changes of polarity.
CDK-5 was recently shown to recruit the MAGUK family member CASK, an active zone protein that interacts with calcium channels and multiple adaptor proteins, to presynaptic sites (Samuels et al., 2007). In C. elegans, the phenotype of a strong assembly defect in DA9 is distinct from the defect in mutants in the two CDK pathways (Figure S5S-T). Therefore, while CDK-5 might also affect the local assembly of presynaptic specializations in DA9, it is unlikely that the CDKs maintain proper localization of presynaptic components solely through regulating synapse assembly.
Our genetic and cell biology experiments suggest that the CDK pathways affect intracellular trafficking by regulating motor proteins. Several studies support the involvement of CDK-5 or its related kinase in axonal transport. First, in the squid giant axon, the CDK inhibitor olomoucin affects fast anterograde movement while substrates for proline-directed kinases like KSPXK peptide and histone H1 decrease both anterograde and retrograde transport (Ratner et al., 1998). Second, adding the CDK inhibitor olomoucin or knocking out CDK-5 activators p35 or p39 increases kinesin light chain phosphorylation, which may cause cargo release and the slowing down of fast anterograde axonal transport of membrane-bound organelles (Morfini et al., 2004; Morfini et al., 2002). Thirdly and most relevant to this study, a series of elegant biochemistry studies showed that CDK-5 phosphorylates Nudel, a factor that associates with the retrograde motor dynein and its regulator LIS1 and this phosphorylation event regulates neuronal migration and neurite morphology (Niethammer et al., 2000; Sasaki et al., 2000). Taken together, CDK-5 and its related kinases regulate the balance of anterograde and retrograde motors. Since the defect of SVP localization can be restored largely by the dhc-1 and nud-2 mutations (Figure 7), we propose that CDK-5 and PCT-1 mainly repress retrograde transport to localize presynaptic components to axons and this may occur through the dynein complex.
Interactions between PCT-1/CYY-1 and CDK-5/p35
Our genetic double mutant analysis showed that PCT-1 and CYY-1 function in the same genetic pathway, while CDK-5 and CDKA-1/p35 act together. This notion is supported by the fact that CYY-1 binds directly to PCT-1 and is required for the kinase activity of PCT-1 in vitro. However, CYY-1 might also stimulate the activity of the CDK-5 pathway as a CYY-1 transgene can rescue the pct-1 mutant but not pct-1 cdk-5 double mutants. CDK-5 and its activators p35 and p39 are evolutionarily conserved across eukaryotic species and no cyclin-like activators of CDK-5 have been characterized. It is intriguing that our genetic studies suggest that the CYY-1 can act upstream of CDK-5 and its activator CDKA-1/p35. Moreover, although canonical cyclins cannot affect CDK-5 activity, they can still bind CDK-5 (Miyajima et al., 1995; Yip et al., 2007). Consistent with our genetic analysis, we found that CYY-1 can efficiently stimulate CDK-5 kinase activity in vitro. How CYY-1 regulates PCT-1 and CDK-5 to target presynaptic components in a spatially specific manner is worth investigating, especially since other cyclins generally behave as temporal regulators.
Strains and Genetics
Worms were raised on OP50 E. coli seeded NGM plates at 22°C. The following mutant strains were obtained through the Caenorhabditis Genetics Center: RB814 cdk-5(ok626)III, CB1265 unc-104(e1265)II, RB1471 pct-1(ok1707)IV, WM99 cdk-1(ne2257)II, JH1288 cdk-7(ax224I), CZ1893 syd-1(ju82)II, and RB1022 nud-2(ok949)I. FX00648 cdka-1(tm648)III, FX02175 pct-1(tm2175)IV, and FX01238 cdk-8(tm1238)I were kindly provided by Shohei Mitani. NM1489 dhc-1(js319); jsIs37 was kindly provided by Mike Nonet. TV74 syd-2(wy5)X, a null allele(Chao, unpublished), and TV6851 unc-104(e1265wy565), a weak allele (Shen, unpublished) was previously isolated from our lab. N2 Bristol was utilized as the wild-type reference strain.
Genetic Screens
wy575 was isolated from an F2 semiclonal visual screen of 600 haploid genomes for lin-44/wnt(n1792); wyIs85 enhancers. wy302 was isolated from an F2 semiclonal visual screen of 3,000 haploid genomes from the wyIs109 strain. wy622 was isolated from an F2 semiclonal visual screen of 3,000 haploid genomes for cdk-5(ok626); wyIs85 enhancers. wy565 was isolated from an F2 behavioral screen of 1,200 haploid genomes for unc-104(e1265); wyIs87 suppressors. Worms were mutagenized with 50 mM EMS.
Cloning and Constructs
Expression clones were made in a derivative of pPD49.26 (A. Fire), the pSM vector (S. McCarroll and C. I. Bargmann, personal communication). The plasmids and strains were generated as previously described (Klassen and Shen, 2007; Margeta et al., 2009). We utilized the coinjection markers Podr-1::GFP or dsRED injected at 20ng μl-1 and transgenes were introduced into C. elegans as previously described (Mello and Fire, 1995).
Fluorescence Microscopy and Confocal Imaging
Images of fluorescently-tagged fusion proteins were captured in live C. elegans using a Plan-Apochromat 63X/1.4 objective on a Zeiss LSM510 or LSM710 confocal microscope. Worms were immobilized using 1.25mM levamisole (Sigma) and 112.5mM 2,3-butanedione monoxime (Sigma).
Electron Microscopy
N2 and cyy-1 cdk-5 animals were processed for electron microscopy essentially as previously described (Hammarlund et al., 2007) and supplement methods. A total of ~12μm segments were reconstructed for each strain and annotated using ImageJ. The DA, DB, and DD neurons were recognized by their orientation pattern (White, 1986). A varicosity was defined as a series of profiles with an area larger than 10,000 square nm. In N2 animals, seven DA, six DB, and five DD varicosities were analyzed. In cyy-1 cdk-5 double mutants, eight DA, four DB, and six DD varicosities were analyzed.
Dynamic imaging
Dynamic imaging was performed on the inverted Zeiss Axio Observer Z1 microscope equipped with the highly sensitive QuantEM:512SC camera. A Plan-Apochromat 63X/1.4 objective was used for acquisition.
L4 worms were cultured at 25°C for imaging. They were mounted onto 2% agarose pads and anesthetized with 6mM levamisol (Sigma) for no longer than 20min.
All movies were acquired over 40 seconds with 7 frames per second and an illumination time of 100ms. Movies were then analyzed using the ImageJ software.
Co-immunoprecipitation and kinase activity assays
Mammalian expression constructs encoding C. elegans CYY-1-FLAG and PCT-1-HA were overexpressed in HEK 293T cells by lipofectamine plus (Invitrogen) and co-immunoprecipated by anti-FLAG (Sigma) or anti-HA (Roche) antibodies (2 μg) as previously described (Fu et al., 2007).
For in vitro kinase assays, mammalian expression constructs encoding C. elegans CYY-1-FLAG with PCT-1-HA or CDK-5-HA were overexpressed in HEK 293T cells as previously described (Cheng et al., 2002). The PCT-1 or CDK-5 complex was co-immunoprecipitated using anti-HA antibody (Santa Cruz). Recombinant myelin basic protein (0.5 mg; Calbiochem) or recombinant Histone H1 protein (5 μg; Calbiochem) was used as a substrate for PCT-1 or CDK-5 respectively in the in vitro kinase assays.
Supplementary Material
01
Acknowledgments
This work was supported by the Human Frontier Science Foundation, the W.M. Keck Foundation, and the Howard Hughes Medical Institute. We thank the International C. elegans Gene Knockout Consortium, the National Bioresource Project-Japan, and the Nonet lab for strains. We also thank Y. Wu, M. Margeta, C. Gao, and Y. Fu for technical assistance, and C. Bargmann, L.H. Tsai, and members of the Shen lab for thoughtful comments on the manuscript.
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  • Baas PW, Deitch JS, Black MM, Banker GA. Polarity orientation of microtubules in hippocampal neurons: uniformity in the axon and nonuniformity in the dendrite. Proc Natl Acad Sci U S A. 1988;85:8335–8339. [PubMed]
  • Burack MA, Silverman MA, Banker G. The role of selective transport in neuronal protein sorting. Neuron. 2000;26:465–472. [PubMed]
  • Cai Q, Pan PY, Sheng ZH. Syntabulin-kinesin-1 family member 5B-mediated axonal transport contributes to activity-dependent presynaptic assembly. J Neurosci. 2007;27:7284–7296. [PubMed]
  • Cheng K, Li Z, Fu WY, Wang JH, Fu AK, Ip NY. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35. J Biol Chem. 2002;277:31988–31993. [PubMed]
  • Cheung ZH, Fu AK, Ip NY. Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron. 2006;50:13–18. [PubMed]
  • Fejtova A, Davydova D, Bischof F, Lazarevic V, Altrock WD, Romorini S, Schone C, Zuschratter W, Kreutz MR, Garner CC, et al. Dynein light chain regulates axonal trafficking and synaptic levels of Bassoon. The Journal of cell biology. 2009;185:341–355. [PMC free article] [PubMed]
  • Fu WY, Chen Y, Sahin M, Zhao XS, Shi L, Bikoff JB, Lai KO, Yung WH, Fu AK, Greenberg ME, et al. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat Neurosci. 2007;10:67–76. [PubMed]
  • Furukawa Y, Kikuchi J, Nakamura M, Iwase S, Yamada H, Matsuda M. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation. Br J Haematol. 2000;110:663–673. [PubMed]
  • Garrido JJ, Fernandes F, Giraud P, Mouret I, Pasqualini E, Fache MP, Jullien F, Dargent B. Identification of an axonal determinant in the C-terminus of the sodium channel Na(v)1.2. The EMBO journal. 2001;20:5950–5961. [PubMed]
  • Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci. 1998;18:6370–6377. [PubMed]
  • Graeser R, Gannon J, Poon RY, Dubois T, Aitken A, Hunt T. Regulation of the CDK-related protein kinase PCTAIRE-1 and its possible role in neurite outgrowth in Neuro-2A cells. J Cell Sci. 2002;115:3479–3490. [PubMed]
  • Hall DH, Hedgecock EM. Kinesin-related gene unc-104 is required for axonal transport of synaptic vesicles in C. elegans. Cell. 1991;65:837–847. [PubMed]
  • Hammarlund M, Palfreyman MT, Watanabe S, Olsen S, Jorgensen EM. Open syntaxin docks synaptic vesicles. PLoS Biol. 2007;5:e198. [PMC free article] [PubMed]
  • Herskovits AZ, Davies P. The regulation of tau phosphorylation by PCTAIRE 3: implications for the pathogenesis of Alzheimer’s disease. Neurobiol Dis. 2006;23:398–408. [PubMed]
  • Hirokawa N, Takemura R. Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci. 2005;6:201–214. [PubMed]
  • Horton AC, Ehlers MD. Neuronal polarity and trafficking. Neuron. 2003;40:277–295. [PubMed]
  • Kiess M, Gill RM, Hamel PA. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene. 1995;10:159–166. [PubMed]
  • Klassen MP, Shen K. Wnt signaling positions neuromuscular connectivity by inhibiting synapse formation in C. elegans. Cell. 2007;130:704–716. [PubMed]
  • Koushika SP, Schaefer AM, Vincent R, Willis JH, Bowerman B, Nonet ML. Mutations in Caenorhabditis elegans cytoplasmic dynein components reveal specificity of neuronal retrograde cargo. J Neurosci. 2004;24:3907–3916. [PubMed]
  • Kwon YT, Tsai LH. A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol. 1998;395:510–522. [PubMed]
  • Le Bouffant F, Capdevielle J, Guillemot JC, Sladeczek F. Characterization of brain PCTAIRE-1 kinase immunoreactivity and its interactions with p11 and 14-3-3 proteins. European journal of biochemistry / FEBS. 1998;257:112–120. [PubMed]
  • Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH. A brain-specific activator of cyclin-dependent kinase 5. Nature. 1994;371:423–426. [PubMed]
  • Liu Y, Cheng K, Gong K, Fu AK, Ip NY. Pctaire1 phosphorylates N-ethylmaleimide-sensitive fusion protein: implications in the regulation of its hexamerization and exocytosis. J Biol Chem. 2006;281:9852–9858. [PubMed]
  • Ma S, Chisholm RL. Cytoplasmic dynein-associated structures move bidirectionally in vivo. J Cell Sci. 2002;115:1453–1460. [PubMed]
  • Margeta MA, Wang GJ, Shen K. Clathrin adaptor AP-1 complex excludes multiple postsynaptic receptors from axons in C. elegans. Proc Natl Acad Sci U S A. 2009;106:1632–1637. [PubMed]
  • Mello C, Fire A. DNA transformation. Methods Cell Biol. 1995;48:451–482. [PubMed]
  • Meyyappan M, Wong H, Hull C, Riabowol KT. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol. 1998;18:3163–3172. [PMC free article] [PubMed]
  • Miyajima M, Nornes HO, Neuman T. Cyclin E is expressed in neurons and forms complexes with cdk5. Neuroreport. 1995;6:1130–1132. [PubMed]
  • Morfini G, Szebenyi G, Brown H, Pant HC, Pigino G, DeBoer S, Beffert U, Brady ST. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. The EMBO journal. 2004;23:2235–2245. [PubMed]
  • Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. The EMBO journal. 2002;21:281–293. [PubMed]
  • Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, Morabito M, Tsai LH. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron. 2000;28:697–711. [PubMed]
  • Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A. 1996;93:11173–11178. [PubMed]
  • Pack-Chung E, Kurshan PT, Dickman DK, Schwarz TL. A Drosophila kinesin required for synaptic bouton formation and synaptic vesicle transport. Nat Neurosci. 2007;10:980–989. [PubMed]
  • Poon VY, Klassen MP, Shen K. UNC-6/netrin and its receptor UNC-5 locally exclude presynaptic components from dendrites. Nature. 2008;455:669–673. [PMC free article] [PubMed]
  • Ratner N, Bloom GS, Brady ST. A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein. J Neurosci. 1998;18:7717–7726. [PubMed]
  • Sampo B, Kaech S, Kunz S, Banker G. Two distinct mechanisms target membrane proteins to the axonal surface. Neuron. 2003;37:611–624. [PubMed]
  • Samuels BA, Hsueh YP, Shu T, Liang H, Tseng HC, Hong CJ, Su SC, Volker J, Neve RL, Yue DT, et al. Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK. Neuron. 2007;56:823–837. [PMC free article] [PubMed]
  • Sasaki S, Shionoya A, Ishida M, Gambello MJ, Yingling J, Wynshaw-Boris A, Hirotsune S. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron. 2000;28:681–696. [PubMed]
  • Sato-Yoshitake R, Yorifuji H, Inagaki M, Hirokawa N. The phosphorylation of kinesin regulates its binding to synaptic vesicles. J Biol Chem. 1992;267:23930–23936. [PubMed]
  • Setou M, Nakagawa T, Seog DH, Hirokawa N. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science. 2000;288:1796–1802. [PubMed]
  • Sieburth D, Ch’ng Q, Dybbs M, Tavazoie M, Kennedy S, Wang D, Dupuy D, Rual JF, Hill DE, Vidal M, et al. Systematic analysis of genes required for synapse structure and function. Nature. 2005;436:510–517. [PubMed]
  • Smith D. Cdk5 in neuroskeletal dynamics. Neurosignals. 2003;12:239–251. [PubMed]
  • Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui H. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci. 2002;22:2590–2597. [PubMed]
  • Tsai LH, Delalle I, Caviness VS, Jr, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 1994;371:419–423. [PubMed]
  • Uchida T, Ishiguro K, Ohnuma J, Takamatsu M, Yonekura S, Imahori K. Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: its sequence and developmental change in brain. FEBS Lett. 1994;355:35–40. [PubMed]
  • Vale RD. The molecular motor toolbox for intracellular transport. Cell. 2003;112:467–480. [PubMed]
  • White JG, Southgate E, Thomson JN, Brenner S. The structure of the ventral nerve cord of Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci. 1976;275:327–348. [PubMed]
  • White JG, Southgate E, Thomson JN, Brenner S. The structure of the nervous system of the nematode caenorhabditis elegans. Philosophical Transactions of the royal society of London Series B, Biological Sciences. 1986;314:340. [PubMed]
  • Wisco D, Anderson ED, Chang MC, Norden C, Boiko T, Folsch H, Winckler B. Uncovering multiple axonal targeting pathways in hippocampal neurons. The Journal of cell biology. 2003;162:1317–1328. [PMC free article] [PubMed]
  • Xie Z, Samuels BA, Tsai LH. Cyclin-dependent kinase 5 permits efficient cytoskeletal remodeling--a hypothesis on neuronal migration. Cereb Cortex. 2006;16(Suppl 1):i64–68. [PubMed]
  • Yamochi T, Nishimoto I, Okuda T, Matsuoka M. ik3-1/Cables is associated with Trap and Pctaire2. Biochem Biophys Res Commun. 2001;286:1045–1050. [PubMed]
  • Yap CC, Wisco D, Kujala P, Lasiecka ZM, Cannon JT, Chang MC, Hirling H, Klumperman J, Winckler B. The somatodendritic endosomal regulator NEEP21 facilitates axonal targeting of L1/NgCAM. The Journal of cell biology. 2008;180:827–842. [PMC free article] [PubMed]
  • Yip YP, Capriotti C, Drill E, Tsai LH, Yip JW. Cdk5 selectively affects the migration of different populations of neurons in the developing spinal cord. J Comp Neurol. 2007;503:297–307. [PubMed]
  • Zahn TR, Angleson JK, MacMorris MA, Domke E, Hutton JF, Schwartz C, Hutton JC. Dense core vesicle dynamics in Caenorhabditis elegans neurons and the role of kinesin UNC-104. Traffic. 2004;5:544–559. [PubMed]